Elixinol Global Sells Majority Stake in Elixinol Japan

- December 3rd, 2019

Elixinol Global released an update regarding Elixinol Japan following its review of its Japanese operations in October.

Elixinol Global (ASX:EXL;OTCQX:ELLXF) released an update on Monday (December 2) regarding Elixinol Japan following its review of its Japanese operations as notified to the market in October.

As quoted in the press release:

The Company assessed various commercial alternatives for its Japanese business. As a result, Elixinol Global has agreed to sell its 50.5% interest in Elixinol Japan to Mr Takeshi Sakurada who is one of the other shareholders of Elixinol Japan.

The net profit impact of the sale of Elixinol Japan on the Company is expected to be a loss of A$2.2m. Andrew Duff, Chairman of the Company, said “We have made an important decision to move to a licensing model for Japan and to press ahead with our growth priorities in our key markets. We look forward to focusing our efforts on building our distribution channels in North America and Europe and reinforcing a positive and growth-focused culture within our business.”

Click here to read the full press release.

Find out what experts are saying about the future of cannabis

 
Read our 2019 conference report today
 

Get the latest Australia Investing stock information

Get the latest information about companies associated with Australia Investing Delivered directly to your inbox.

Australia Investing

Select None
Select All

Leave a Reply